Our Company

RemeGen was cofounded in 2008 by Mr. Wang Weidong founder of Rongchang Pharmaceuticals a leading traditional Chinese medicine company in China and Dr. Fang Jianmin a Canadian-American scientist. Headquartered in the coastal city of Yantai Shandong Province of China RemeGen has research labs and offices throughout China and the United States. RemeGen is committed to the discovery development and commercialization of innovative and differentiated biologic drugs of significant clinical value in the key therapeutic areas of autoimmune oncology and ophthalmic diseases.

Our Vision

Our mission is to discover develop produce and commercialize first-in-class and best-in-class biological drugs for autoimmune oncology ophthalmology and other major diseases to create clinical value meet the major unmet clinical needs of the world and maximize the value of the company.
Our vision is to become a leading world-class bio-pharmaceutical company in both China and the world.

Our Board of Directors

Executive Director

  • Weidong Wang

    Executive Director and Chairman of the Board

  • Jianmin Fang

    Executive Director and Chief Executive Officer

  • Ruyi He

    Executive Director, Chief Medical Officer and Head of Clinical Research

  • Jian Lin

    Executive Director

Non-Executive Director

Independent Non-Executive Director

Our Management Team

Weidong Wang

Co-Founder

Board Chairman
Jianmin Fang

Co-Founder

CEO
Ruyi He

Chief Medical Officer
Zhulun Wang

Chief Scientific Officer
Kaisheng Huang

Chief Operating Officer
Xiaoming Yang

Chief Manufacturing Officer
Shaojing Tong

Chief Financial Officer
Dan Ross

Chief Business Officer

Scientific Advisory Board

We have also established our Scientific Advisory Board which currently comprises five renowned professors and key opinion leaders in the areas of our research and development, including Dr. Pei Gang, Dr. Fang Jianmin, Dr. He Ruyi, Dr. Marsha A. Moses and Dr. Lorne Babiuk.
See the Details

Members of our Scientific Advisory Board routinely meet or communicate with us and provide us with advisory services, including

Advice in respect of our business strategies and objectives

Academic updates and technical insights relevant to our research and development plans

Recommendations relating to innovative drug targets, mechanisms and modalities

Advice on new drug discovery projects

Biopharmaceutical market data and intelligence

About Us

Products

R & D

Investors

News

Join Us

Contact Us

58 Beijing Middle Road, Yantai Shandong, China.

（+86）0535-3573511

Company Wechat
Company Wechat

鲁公网安备37069302889101工信部网站备案号：鲁ICP备11031710号-4